Clinical Trial Update: A Study to Evaluate Efficacy and Safety of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of QPI-1002 for prevention of acute kidney injury after cardiac surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• QPI-1002

Snippet

Sponsor: Quark Pharmaceuticals | Conditions: Acute Kidney Injury | Phase 2 | Status: COMPLETED